BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 11961407)

  • 41. Novel expression of sodium/myo-inositol co-transporter in podocytes in puromycin aminonucleoside nephrosis.
    Watanabe Y; Kobayashi T; Yaoita E; Kawachi H; Yamauchi A; Inoue T; Shimizu F; Yoshida Y; El-Shemi AG; Okada H; Suzuki H; Yamamoto T
    Nephrol Dial Transplant; 2004 Apr; 19(4):817-22. PubMed ID: 15031335
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Re-evaluation of foot process effacement in acute puromycin aminonucleoside nephrosis.
    Inokuchi S; Shirato I; Kobayashi N; Koide H; Tomino Y; Sakai T
    Kidney Int; 1996 Oct; 50(4):1278-87. PubMed ID: 8887289
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fluvastatin ameliorates podocyte injury in proteinuric rats via modulation of excessive Rho signaling.
    Shibata S; Nagase M; Fujita T
    J Am Soc Nephrol; 2006 Mar; 17(3):754-64. PubMed ID: 16452496
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Podoplanin, novel 43-kd membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis.
    Breiteneder-Geleff S; Matsui K; Soleiman A; Meraner P; Poczewski H; Kalt R; Schaffner G; Kerjaschki D
    Am J Pathol; 1997 Oct; 151(4):1141-52. PubMed ID: 9327748
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Glomerular expression of smooth-muscle myosin heavy-chain isoforms in aminonucleoside nephrosis in rats.
    Nakamura T; Kimura K; Ebihara I; Takahashi T; Tomino Y; Aikawa M; Yazaki Y; Nagai R; Koide H
    Clin Sci (Lond); 1995 Jul; 89(1):45-52. PubMed ID: 7671567
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alterations in the sialic acid content of the rat glomerular filter in aminonucleoside nephrosis.
    Quatacker J
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1986; 50(3):237-47. PubMed ID: 2870576
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Glomerular epithelial detachment, not reduced charge density, correlates with proteinuria in adriamycin and puromycin nephrosis.
    Whiteside C; Prutis K; Cameron R; Thompson J
    Lab Invest; 1989 Dec; 61(6):650-60. PubMed ID: 2601299
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Podocyte architecture in puromycin aminonucleoside-treated rats administered tungsten or allopurinol.
    Ricardo SD; Bertram JF; Ryan GB
    Exp Nephrol; 1995; 3(5):270-9. PubMed ID: 7583048
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ultrastructural changes in glomerular epithelial cells in acute puromycin aminonucleoside nephrosis: a study by high-resolution scanning electron microscopy.
    Inokuchi S; Sakai T; Shirato I; Tomino Y; Koide H
    Virchows Arch A Pathol Anat Histopathol; 1993; 423(2):111-9. PubMed ID: 8212539
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sialic acid supplementation ameliorates puromycin aminonucleoside nephrosis in rats.
    Pawluczyk IZ; Najafabadi MG; Brown JR; Bevington A; Topham PS
    Lab Invest; 2015 Sep; 95(9):1019-28. PubMed ID: 26121320
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reduced sialylation of podocalyxin--the major sialoprotein of the rat kidney glomerulus--in aminonucleoside nephrosis.
    Kerjaschki D; Vernillo AT; Farquhar MG
    Am J Pathol; 1985 Mar; 118(3):343-9. PubMed ID: 3976840
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A novel nuclear factor κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates puromycin aminonucleoside-induced nephrosis in mice.
    Shimo T; Adachi Y; Yamanouchi S; Tsuji S; Kimata T; Umezawa K; Okigaki M; Takaya J; Ikehara S; Kaneko K
    Am J Nephrol; 2013; 37(4):302-9. PubMed ID: 23548793
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of heparin-binding epidermal growth factor-like growth factor increases albuminuria in puromycin aminonucleoside nephrosis.
    Khong TF; Fraser S; Katerelos M; Paizis K; Hill PA; Power DA
    Kidney Int; 2000 Sep; 58(3):1098-107. PubMed ID: 10972674
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Decreased tyrosine phosphorylation of nephrin in rat and human nephrosis.
    Uchida K; Suzuki K; Iwamoto M; Kawachi H; Ohno M; Horita S; Nitta K
    Kidney Int; 2008 Apr; 73(8):926-32. PubMed ID: 18256598
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular cloning of cDNAs encoding human GLEPP1, a membrane protein tyrosine phosphatase: characterization of the GLEPP1 protein distribution in human kidney and assignment of the GLEPP1 gene to human chromosome 12p12-p13.
    Wiggins RC; Wiggins JE; Goyal M; Wharram BL; Thomas PE
    Genomics; 1995 May; 27(1):174-81. PubMed ID: 7665166
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of progression of chronic puromycin aminonucleoside nephrosis by probucol, an antioxidant.
    Magil A
    J Am Soc Nephrol; 1996 Nov; 7(11):2340-7. PubMed ID: 8959623
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Glomerular tumor necrosis factor and interleukin 1 during acute aminonucleoside nephrosis. An immunohistochemical study.
    Diamond JR; Pesek I
    Lab Invest; 1991 Jan; 64(1):21-8. PubMed ID: 1990206
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of glomerular visceral epithelial cell endocytosis during nephrosis induced by puromycin aminonucleoside.
    Schwartz MM; Sharon Z; Pauli BU; Lewis EJ
    Lab Invest; 1984 Dec; 51(6):690-6. PubMed ID: 6389977
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cortactin interacts with podocalyxin and mediates morphological change of podocytes through its phosphorylation.
    Kobayashi T; Notoya M; Shinosaki T; Kurihara H
    Nephron Exp Nephrol; 2009; 113(3):e89-96. PubMed ID: 19684413
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synaptic vesicle protein 2B is expressed in podocyte, and its expression is altered in proteinuric glomeruli.
    Miyauchi N; Saito A; Karasawa T; Harita Y; Suzuki K; Koike H; Han GD; Shimizu F; Kawachi H
    J Am Soc Nephrol; 2006 Oct; 17(10):2748-59. PubMed ID: 16943307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.